Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.
A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
[Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
Functional neuroimaging may quantify spinal cord demyelinating disease.
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Multiple Sclerosis: Methods and Protocols. Preface.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate].
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Specialty drug spending trends among medicare and medicare advantage enrollees, 2007-11.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.
Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.
The relationship between fear of falling to spatiotemporal gait parameters measured by an instrumented treadmill in people with multiple sclerosis.
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
CNS accumulation of regulatory B cells is VLA-4-dependent.
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells.
Micro RNA-155 participates in re-activation of encephalitogenic T cells.
Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
Pages
« first
‹ previous
…
585
586
587
588
589
590
591
592
593
…
next ›
last »